BridgeMD
Tests treatment safety and results for Respiratory Insufficiency
Official title Effectiveness of Platform-Based Lateralization Therapy in Reducing Interface Pressure Between The Patient And The Support Surface
ClinicalTrials.gov ID: NCT06819943
What this study is testing
- What it's testing
- Pressure injury (PI) is characterized as damage to the skin and/or underlying tissues resulting from sustained pressure or a combination of pressure and shear forces between the patient and the support surface. Prolonged pressure is a well-established risk factor in the development of PIs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult and elderly patients, aged 18 years or older;
- Patients under controlled or assisted mechanical ventilation, not yet eligible for weaning.
You likely can't join if
- Requirement of norepinephrine \> 0.3 mcg/kg/min or mean arterial pressure \< 60 mmHg, despite the use of vasopressor agents;
- Cardiac arrhythmias or bleeding leading to hemodynamic instability;
- Neurological diseases or symptoms;
- Spinal cord injury, such as paraplegia;
- Cardiac pacemaker dependence;
- Contraindications to hypercapnia, such as intracranial hypertension or acute coronary syndrome;
See the full eligibility criteria
- Adult and elderly patients, aged 18 years or older;
- Patients under controlled or assisted mechanical ventilation, not yet eligible for weaning.
- Requirement of norepinephrine \> 0.3 mcg/kg/min or mean arterial pressure \< 60 mmHg, despite the use of vasopressor agents;
- Cardiac arrhythmias or bleeding leading to hemodynamic instability;
- Neurological diseases or symptoms;
- Spinal cord injury, such as paraplegia;
- Cardiac pacemaker dependence;
- Contraindications to hypercapnia, such as intracranial hypertension or acute coronary syndrome;
- Air leakage from chest drains, presence of pneumothorax or undrained subcutaneous emphysema;
- Presence of pre-existing pressure injuries in bony prominences (sacral, occipital, scapular, or calcaneal) at admission;
- Medical refusal to include the patient in the study.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.